GABELLI FUNDS LLC
Q2 2025 13F-HR Holdings
Net value change ($000)
+962,790
(7.3%)
New positions
189
Sold out positions
65
Turnover %
5.9%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q1 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| NVDA | 63,734 | 45.9% |
| MSFT | 63,411 | 31.9% |
| AVGO | 35,647 | 83.1% |
| NFLX | 31,315 | 42.6% |
| SpringWorks Therapeutics, Inc. | 30,336 | 1715.8% |
| B | 30,102 | NEW |
| CR | 27,390 | 22.8% |
| BPMC | 27,068 | NEW |
| META | 24,638 | 24.0% |
| GE | 20,224 | 29.1% |
Top Reduces (Value $000, Stocks/ETFs)
| Intra-Cellular Therapies, Inc. | -42,966 | -100.0% |
| B | -39,285 | -100.0% |
| QXO BUILDING PRODUCTS, INC. | -20,639 | -100.0% |
| DFS | -18,009 | -100.0% |
| Paragon 28, Inc. | -16,794 | -100.0% |
| OKE | -15,052 | -17.9% |
| Despegar.com, Corp. | -14,076 | -100.0% |
| Air Transport Services Group, Inc. | -13,619 | -100.0% |
| H&E Equipment Services, Inc. | -12,652 | -100.0% |
| PFE | -12,475 | -47.3% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|